Comments to "Fluvoxamine and long COVID-19: a new role for sigma-1 receptor (S1R) agonists" by Khani and Entezari-Maleki

被引：6
作者：
Hashimoto, Yaeko [1 ,2 ]
Suzuki, Takuji [1 ]
Hashimoto, Kenji [2 ]
机构：
[1] Chiba Univ, Dept Respirol, Grad Sch Med, Chiba 2608670, Japan
[2] Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, Chiba 2608670, Japan
来源：
MOLECULAR PSYCHIATRY | 2022年 / 27卷 / 09期
基金：
日本学术振兴会;
关键词：
D O I：
10.1038/s41380-022-01546-2
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：3563 / 3564
页数：2
相关论文
共 10 条
[1]   How COVID-19 Affects the Brain [J].
Boldrini, Maura ;
Canoll, Peter D. ;
Klein, Robyn S. .
JAMA PSYCHIATRY, 2021, 78 (06) :682-683
[2]   Positive Epstein-Barr virus detection in coronavirus disease 2019 (COVID-19) patients [J].
Chen, Ting ;
Song, Jiayi ;
Liu, Hongli ;
Zheng, Hongmei ;
Chen, Changzheng .
SCIENTIFIC REPORTS, 2021, 11 (01)
[3]   Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation [J].
Gold, Jeffrey E. ;
Okyay, Ramazan A. ;
Licht, Warren E. ;
Hurley, David J. .
PATHOGENS, 2021, 10 (06)
[4]   In vivo intratumoral Epstein-Barr virus replication is associated with XBP1 activation and early-onset post-transplant lymphoproliferative disorders with prognostic implications [J].
Gonzalez-Farre, Blanca ;
Rovira, Jordina ;
Martinez, Daniel ;
Valera, Alexandra ;
Garcia-Herrera, Adriana ;
Angeles Marcos, Maria ;
Sole, Carla ;
Roue, Gael ;
Colomer, Dolors ;
Gonzalvo, Elena ;
Ribera-Cortada, Imma ;
Araya, Monica ;
Lloreta, Josep ;
Colomo, Luis ;
Campo, Elias ;
Lopez-Guillermo, Armando ;
Martinez, Antonio .
MODERN PATHOLOGY, 2014, 27 (12) :1599-1611
[5]   Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection A Systematic Review [J].
Groff, Destin ;
Sun, Ashley ;
Ssentongo, Anna E. ;
Ba, Djibril M. ;
Parsons, Nicholas ;
Poudel, Govinda R. ;
Lekoubou, Alain ;
Oh, John S. ;
Ericson, Jessica E. ;
Ssentongo, Paddy ;
Chinchilli, Vernon M. .
JAMA NETWORK OPEN, 2021, 4 (10)
[6]   Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor [J].
Hashimoto, Kenji .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2021, 271 (02) :249-258
[7]   Mechanisms of action of fluvoxamine for COVID-19: a historical review [J].
Hashimoto, Yaeko ;
Suzuki, Takuji ;
Hashimoto, Kenji .
MOLECULAR PSYCHIATRY, 2022, 27 (04) :1898-1907
[8]   Old drug fluvoxamine, new hope for COVID-19 [J].
Hashimoto, Yaeko ;
Suzuki, Takuji ;
Hashimoto, Kenji .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2022, 272 (01) :161-163
[9]   Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists [J].
Khani, Elnaz ;
Entezari-Maleki, Taher .
MOLECULAR PSYCHIATRY, 2022, 27 (09) :3562-3562
[10]   Modulation of the sigma-1 receptor-IRE1 pathway is beneficial in preclinical models of inflammation and sepsis [J].
Rosen, Dorian A. ;
Seki, Scott M. ;
Fernandez-Castaneda, Anthony ;
Beiter, Rebecca M. ;
Eccles, Jacob D. ;
Woodfolk, Judith A. ;
Gaultier, Alban .
SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (478)
1